89bio Inc Strategic Asset Allocation Index

Latest as of June 2023: 0.0%

89bio Inc strategic asset allocation index. 89bio Inc (ETNB) has a Strategic Asset Allocation Index of 0.0% as of June 2023. Strategic assets (PP&E of $68.00K plus long-term investments of $-) total $68.00K, measured against net assets of $441.99 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See ETNB equity to assets ratio to measure how much of total assets are equity-financed.

SAAI

0.0%
Strategic Assets / Net Assets

Strategic Assets

$68.00K
PP&E + LT Investments

PP&E

$68.00K
USD

Net Assets

$441.99 Million
USD

Strategic Asset Allocation Index of 89bio Inc (2019–2022)

Strategic asset allocation index of 89bio Inc from 2019 to 2022. This chart shows how 89bio Inc's Strategic Asset Allocation Index has evolved across 4 annual periods from 2019 to 2022. As of June 2023, the index stands at 0.0%, representing strategic assets of $68.00K against net assets of $441.99 Million USD. Check ETNB intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

89bio Inc Strategic Asset Allocation Index by Year (2019–2022)

89bio Inc strategic asset allocation index by year from 2019 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for 89bio Inc from 2019 to 2022, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 89bio Inc (ETNB) total market value.

Year SAAI Strategic Assets (USD) PP&E LT Investments Net Assets Change (pp)
2022 0.1% $92.00K $92.00K $- $151.83 Million ▼ -0.1 pp
2021 0.1% $150.00K $150.00K $- $125.96 Million ▲ +0.0 pp
2020 0.1% $166.00K $166.00K $- $202.96 Million ▼ -0.1 pp
2019 0.2% $155.00K $155.00K $- $89.94 Million —
pp = percentage points